Comparison scoring model of severe viral hepatitis and model of end stage liver disease for the prognosis of patients with liver failure in China

World Journal of Gastroenterology

Volumn 13, Issue 21, 2007, Pages 2999-3002

  Zhou, Li ^a   Dong, Pei Ling ^a   Ding, Hui Guo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Liver failure; Scoring model; Survival analysis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; VIRUS HEPATITIS;

EID: 34447101227     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i21.2999     Document Type: Article

References (15)

1. Ding HG, Xiang HP, Shan J, Zhou L, Ma B, Liu M, Wang JT. A scoring model for predicting the prognosis of severe viral hepatitis. Chin Med J (Engl) 2005; 118: 249-251
2. Auth MK. Are hepatic growth factors predictors of clinical outcome in fulminant hepatic failure? J Pediatr Gastroenterol Nutr 2007; 44: 168-170
3. Riordan SM, Williams R. Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol 2000; 32: 63-76
4. Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology 2001; 33: 473-475
5. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6: 163-169
6. Taylor RM, Davern T, Munoz S, Han SH, McGuire B, Larson AM, Hynan L, Lee WM, Fontana RJ. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology 2006; 44: 1589-1597
7. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005; 42 Suppl: S100-S107
8. Yu JW, Wang GQ, Li SC. Prediction of the prognosis in patients with acute-on-chronic hepatitis using the MELD scoring system. J Gastroenterol Hepatol 2006; 21: 1519-1524
9. Cucchetti A, Ercolani G, Cescon M, Ravaioli M, Zanello M, Del Gaudio M, Lauro A, Vivarelli M, Grazi GL, Pinna AD. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg 2006; 203: 670-676
10. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871
11. Ding HG, Shan J, Zhang B, Ma HB, Zhou L, Jin R, Tan YF, He LX. Combined human growth hormone and lactulose for prevention and treatment of multiple organ dysfunction in patients with severe chronic hepatitis B. World J Gastroenterol 2005; 11: 2981-2983
12. Uka K, Aikata H, Takaki S, Shirakawa H, Jeong SC, Yamashina K, Hiramatsu A, Kodama H, Takahashi S, Chayama K. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 2007; 13: 414-420
13. Cholongitas E, Senzolo M, Patch D, Kwong K, Nikolopoulou V, Leandro G, Shaw S, Burroughs AK. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 2006; 23: 883-893
14. Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, Meregaglia D, Nicolini A, Lubatti L, Riggio O. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36: 494-500
15. Blendis L. Child, MELD, hyporiatremia, and now portal pressure. Gastroenterology 2006; 130: 1920-1921; discussion 1921-1922